These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 11904529

  • 21. Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers.
    Pieniaszek HJ, Sy SK, Ebling W, Fossler MJ, Cain VA, Mondick JT, Ma S, Kornhauser DM.
    J Clin Pharmacol; 2002 Jul; 42(7):738-53. PubMed ID: 12092741
    [Abstract] [Full Text] [Related]

  • 22. Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes.
    Cox D, Smith R, Quinn M, Theroux P, Crean P, Fitzgerald DJ.
    J Am Coll Cardiol; 2000 Nov 01; 36(5):1514-9. PubMed ID: 11079651
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes.
    Serrano CV, Nicolau JC, Venturinelli M, Baracioli LM, Anders RJ, Cannon CP, Ramires JA.
    Cardiovasc Drugs Ther; 2003 Mar 01; 17(2):129-32. PubMed ID: 12975594
    [Abstract] [Full Text] [Related]

  • 25. Differential efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet/fibrin-mediated clot dynamics under different conditions using thrombelastography: the critical need for anticoagulant.
    Mousa SA, Forsythe MS, Bozarth JM.
    Coron Artery Dis; 2002 Jun 01; 13(4):243-8. PubMed ID: 12193852
    [Abstract] [Full Text] [Related]

  • 26. Intravenous and oral antithrombotic efficacy of the novel platelet GPIIb/IIIa antagonist roxifiban (DMP754) and its free acid form, XV459.
    Mousa SA, Kapil R, Mu DX.
    Arterioscler Thromb Vasc Biol; 1999 Oct 01; 19(10):2535-41. PubMed ID: 10521384
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Different inhibiting effects of abciximab and tirofiban on platelet thrombus formation on a collagen surface under flow conditions].
    Shimazaki T, Goto S, Sakakibara M, Eto K, Kim JY, Ichikawa N, Yoshida M, Nagaoka Y, Isshiki T, Handa S.
    J Cardiol; 2000 Aug 01; 36(2):113-21. PubMed ID: 10955255
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
    Moritani Y, Sato K, Shigenaga T, Hisamichi N, Ichihara M, Akamatsu S, Suzuki Ki, Nii T, Kaku S, Kawasaki T, Matsumoto Y, Inagaki O, Tomioka K, Yanagisawa I.
    Eur J Pharmacol; 2002 Mar 29; 439(1-3):43-52. PubMed ID: 11937091
    [Abstract] [Full Text] [Related]

  • 31. Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction.
    Holmes MB, Sobel BE, Cannon CP, Schneider DJ.
    Am J Cardiol; 2000 Feb 15; 85(4):491-3, A10. PubMed ID: 10728957
    [Abstract] [Full Text] [Related]

  • 32. Anti-platelet effects of GPIIb/IIIa and P-selectin antagonism, platelet activation, and binding to neutrophils.
    Caron A, Théorêt JF, Mousa SA, Merhi Y.
    J Cardiovasc Pharmacol; 2002 Aug 15; 40(2):296-306. PubMed ID: 12131559
    [Abstract] [Full Text] [Related]

  • 33. Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin.
    Mousa SA, Forsythe M, Bozarth J, Jin F, Confalone PN.
    Coron Artery Dis; 2000 Oct 15; 11(7):563-70. PubMed ID: 11023245
    [Abstract] [Full Text] [Related]

  • 34. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Goto S, Tamura N, Ishida H, Ruggeri ZM.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):155-62. PubMed ID: 16386680
    [Abstract] [Full Text] [Related]

  • 35. Optimal antagonism of GPIIb/IIIa favors platelet adhesion by inhibiting thrombus growth. An ex vivo capillary perfusion chamber study in the guinea pig.
    André P, Arbeille B, Drouet V, Hainaud P, Bal dit Sollier C, Caen JP, Drouet LO.
    Arterioscler Thromb Vasc Biol; 1996 Jan 03; 16(1):56-63. PubMed ID: 8548427
    [Abstract] [Full Text] [Related]

  • 36. Effect of aspirin on platelet desaggregation induced by SR121566, a potent GP-IIb/IIIa antagonist.
    Savi P, Bernat A, Lalé A, Roque C, Zamboni G, Herbert JM.
    Platelets; 2000 Feb 03; 11(1):43-8. PubMed ID: 10938881
    [Abstract] [Full Text] [Related]

  • 37. Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor.
    Mutlib AE, Diamond S, Shockcor J, Way R, Nemeth G, Gan L, Christ DD.
    Xenobiotica; 2000 Nov 03; 30(11):1091-110. PubMed ID: 11197070
    [Abstract] [Full Text] [Related]

  • 38. Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation.
    Adderley SR, Fitzgerald DJ.
    J Biol Chem; 2000 Feb 25; 275(8):5760-6. PubMed ID: 10681563
    [Abstract] [Full Text] [Related]

  • 39. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA, Gaul SL, Hamill TG, Egbertson MS, Shafer JA, Hartman GD, Gould RJ, Bednar B.
    J Pharmacol Exp Ther; 1998 Jun 25; 285(3):1317-26. PubMed ID: 9618439
    [Abstract] [Full Text] [Related]

  • 40. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M, Ruf A, Pogatsa-Murray G, Dickfeld T, Rüdiger S, Taubitz W, Fischer J, Müller I, Meier D, Patscheke H, Schömig A.
    Thromb Haemost; 2000 Jun 25; 83(6):915-22. PubMed ID: 10896249
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.